The company's shares have an ROE of 32 per cent & an ROCE of 40.7 per cent and has been maintaining a healthy dividend payout of 58.8 per cent.

Company is slated to participate in an Analyst/Investor meet on Tuesday, December 19, 2023, featuring notable entities such as Alchemy, Edelweiss, Mirabilis, Moneybee, Bay Capital, Alpha Accurate, Electrum Capital, JM PMS, Pidilite Family Office, Sahasrar Capital, Incred, and Mahindra MF.

Shares of the company have gained over 40 per cent in the last six months. 

The company's future revenue potential was Rs 2,286.6 crore as of September 30, 2023, based on its order book.

The company's revenue will likely surpass the industry average for the year. Furthermore, more than half of their order book is convertible in the next 12 months, signaling robust revenue visibility.

Its stock price surged by a jaw-dropping 122 per cent, solidifying its status as a multibagger stock. Over the last five years, the company has recorded an impressive 47.7 per cent CAGR in profit growth.